Decreased First-Line Therapy in Older Women With HER2+ MBC Is Associated With Worse Outcomes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database
Breast 2021 Oct 01;[EPub Ahead of Print], M Annonay, L Gauquelin, R Geiss, M Ung, L Cristol-Dalstein, MA Mouret-Reynier, A Goncalves, S Abadie-Lacourtoisie, E Francois, C Perrin, J Le Fel, V Lorgis, V Servent, L Uwer, C Jouannaud, M Leheurteur, F Joly, L Campion, C Courtinard, O Villacroux, T Petit, P Soubeyran, C Terret, C Bellera, E Brain, S DelalogeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.